SrasV1, 2020, Analysis, bibRecord, 000186

Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenzas virus therapies.

Identifieur interne : 000186 ( 2020/Analysis ); précédent : 000185; suivant : 000187

Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenzas virus therapies.

Auteurs : Jiayu Liao [États-Unis] ; George Way [États-Unis] ; Vipul Madahar [États-Unis]

Source :

Medicine in drug discovery [ 2590-0986 ] ; 2020.

RBID : pubmed:32292909

Abstract

The COVID-19 pandemic, after it was reported in December 2019, is a highly contagious and now spreading to over 190 countries, causing a severe public health burden. Currently, there is no vaccine or specific drug to treat COVID-19, which is caused by a novel coronavirus, SARS-2-CoV. For this emergency, the FDA has approved Remdesivir and Hydroxychloroquine for treatment of COVID-19 as Emergency Use Authorization. However, even after this pandemic, COVID-19 may still have a chance to come back. Therefore, we need to come out with new strategies for drug discovery for combating COVID-19 in the future.

DOI: 10.1016/j.medidd.2020.100037
PubMed: 32292909

Affiliations:

Links to Exploration step

pubmed:32292909

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenzas virus therapies.</title>
<author><name sortKey="Liao, Jiayu" sort="Liao, Jiayu" uniqKey="Liao J" first="Jiayu" last="Liao">Jiayu Liao</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Bioengineering, Bourns College of Engineering, University of California at Riverside, 900 University Avenue, Riverside, California 92521.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Department of Bioengineering, Bourns College of Engineering, University of California at Riverside, 900 University Avenue, Riverside</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Way, George" sort="Way, George" uniqKey="Way G" first="George" last="Way">George Way</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Bioengineering, Bourns College of Engineering, University of California at Riverside, 900 University Avenue, Riverside, California 92521.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Department of Bioengineering, Bourns College of Engineering, University of California at Riverside, 900 University Avenue, Riverside</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Madahar, Vipul" sort="Madahar, Vipul" uniqKey="Madahar V" first="Vipul" last="Madahar">Vipul Madahar</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Bioengineering, Bourns College of Engineering, University of California at Riverside, 900 University Avenue, Riverside, California 92521.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Department of Bioengineering, Bourns College of Engineering, University of California at Riverside, 900 University Avenue, Riverside</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32292909</idno>
<idno type="pmid">32292909</idno>
<idno type="doi">10.1016/j.medidd.2020.100037</idno>
<idno type="wicri:Area/PubMed/Corpus">000124</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000124</idno>
<idno type="wicri:Area/PubMed/Curation">000124</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000124</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000154</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000154</idno>
<idno type="wicri:Area/Ncbi/Merge">003A67</idno>
<idno type="wicri:Area/Ncbi/Curation">003A67</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003A67</idno>
<idno type="wicri:Area/Main/Merge">000186</idno>
<idno type="wicri:Area/Main/Curation">000186</idno>
<idno type="wicri:Area/Main/Exploration">000186</idno>
<idno type="wicri:Area/2020/Extraction">000186</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenzas virus therapies.</title>
<author><name sortKey="Liao, Jiayu" sort="Liao, Jiayu" uniqKey="Liao J" first="Jiayu" last="Liao">Jiayu Liao</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Bioengineering, Bourns College of Engineering, University of California at Riverside, 900 University Avenue, Riverside, California 92521.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Department of Bioengineering, Bourns College of Engineering, University of California at Riverside, 900 University Avenue, Riverside</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Way, George" sort="Way, George" uniqKey="Way G" first="George" last="Way">George Way</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Bioengineering, Bourns College of Engineering, University of California at Riverside, 900 University Avenue, Riverside, California 92521.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Department of Bioengineering, Bourns College of Engineering, University of California at Riverside, 900 University Avenue, Riverside</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Madahar, Vipul" sort="Madahar, Vipul" uniqKey="Madahar V" first="Vipul" last="Madahar">Vipul Madahar</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Bioengineering, Bourns College of Engineering, University of California at Riverside, 900 University Avenue, Riverside, California 92521.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Department of Bioengineering, Bourns College of Engineering, University of California at Riverside, 900 University Avenue, Riverside</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Medicine in drug discovery</title>
<idno type="eISSN">2590-0986</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The COVID-19 pandemic, after it was reported in December 2019, is a highly contagious and now spreading to over 190 countries, causing a severe public health burden. Currently, there is no vaccine or specific drug to treat COVID-19, which is caused by a novel coronavirus, SARS-2-CoV. For this emergency, the FDA has approved Remdesivir and Hydroxychloroquine for treatment of COVID-19 as Emergency Use Authorization. However, even after this pandemic, COVID-19 may still have a chance to come back. Therefore, we need to come out with new strategies for drug discovery for combating COVID-19 in the future.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Californie</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Californie"><name sortKey="Liao, Jiayu" sort="Liao, Jiayu" uniqKey="Liao J" first="Jiayu" last="Liao">Jiayu Liao</name>
</region>
<name sortKey="Madahar, Vipul" sort="Madahar, Vipul" uniqKey="Madahar V" first="Vipul" last="Madahar">Vipul Madahar</name>
<name sortKey="Way, George" sort="Way, George" uniqKey="Way G" first="George" last="Way">George Way</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000186 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd -nk 000186 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    2020
   |étape=   Analysis
   |type=    RBID
   |clé=     pubmed:32292909
   |texte=   Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenzas virus therapies.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/RBID.i   -Sk "pubmed:32292909" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

Serveur d'exploration SRAS

Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenzas virus therapies.

Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenzas virus therapies.

Source :

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.